CNS Drugs Journal Issues Research Articles in July 2024 Edition
June 24, 2024
June 24, 2024
CHAM, Switzerland, June 24 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its July 2024 edition (Vol. 38, Issue 7):
* A Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer's Disease
* Targeting Biometals . . .
* A Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer's Disease
* Targeting Biometals . . .